- Display 30 Products per page
Published: March 27, 2018 | Price: $0.00
This brief White Paper lists over one hundred companies that are involved in drug discovery in one form or another. A company website and address is provided for each company. The White Paper does not detail companies or discuss the CRO marketplace - for this purpose, please consult our recent report, Outsourcing in Drug Discovery, 8th Edition.Published: February 26, 2019 | Price:
Published: January 1, 2022 | Price:
How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting task to keep up. Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore. Now from Science and Medicine...Published: August 22, 2022 | Price: $0.00 – $10,000.00
The search for the next large-scale emerging disease was on before the COVID-19 pandemic. Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat. The search is constant, and is by no means limited to respiratory epidemics. As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. This necessitates the development of tests at laboratories. For business planners, it’s worthwhile to have a...Published: September 2, 2022 | Price: $0.00 – $12,000.00
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...Published: September 7, 2022 | Price: $0.00 – $9,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: September 13, 2013 | Price: $50.00 – $100.00
The medical device tax that took effect Jan. 1, 2013 for all manufacturers of Class I, Class II and Class III devices in the United States may have had an impact on device company spending, according to this complimentary Public Policy Paper from Kalorama Information. While the tax was in effect in the 2012 year, the paper looks at budgeted R&D spending as companies anticipated new costs from the program. The conclusions are the result of information from Kalorama Information's...Published: June 7, 2018 | Price: $99.00 – $198.00
A summary of major trends in the IVD industry, from harmonization to Cardiac marker testing.Published: January 1, 2011 | Price: $150.00 – $300.00
Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama's biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as sample preparation, cycle sequencing and sequencing reaction cleanup with capillary systems. The report's perspective is demand-side, focusing on what labs are doing today. The information...Published: February 1, 2011 | Price: $150.00 – $300.00
While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over-the-counter status where possible. In the early part of the last decade there was a decline in Rx-to-OTC switches; since 2006, however, there has been a number of uses of this tactic to extend the revenue of pharmaceutical products. In Kalorama Information's Market for...Published: February 1, 2011 | Price: $150.00 – $300.00
This report covers the U.S. market for Picture Archiving and Communication Systems (PACS) and provides an overview of imaging systems, EMR and PACS technologies and products. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report addresses some of the issues surrounding IT in healthcare and how the PACS arena is affected by these issues. While Kalorama Information has studied EMR markets in great detail in other reports, this report does...Published: February 1, 2011 | Price: $150.00 – $300.00
What are virtual reality technologies and how are they being used in healthcare today? What areas of healthcare are seeing the most use of these products? What is the expected market opportunity for companies entering the market for VR equipment? Who are the main players in the VR market and what moves are they making to grow market share? These are among the questions answered in Kalorama Information's Virtual Reality in Healthcare in the U.S. The use of virtual reality...Published: March 1, 2011 | Price: $150.00 – $300.00
This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not estimates the market for molecular diagnostics and provides a realistic look at the role of molecular testing and its future in various market segments. Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA, also reviews the competitors in the market and their latest moves. There have been many predictions made about a molecular revolution in diagnostics. Indeed some are now taking place, while other...Published: March 1, 2011 | Price: $150.00 – $300.00
For several years Kalorama Information has been studying the trend of electronic medical records (EMR) and electronic health records (EHR). What was already a fast-growing market dramatically changed in 2009 when as part of the ARRA stimulus law, the US Government provided incentives for physicians and hospitals to use systems. Those incentives have now been clarified and in 2011, the first checks have been issued. What will be the impact of those incentives, as well as vendor actions? And what...Published: March 25, 2011 | Price: $150.00 – $300.00
The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets. The population of nearly 4 billion people throughout Asia accounts for more than half of the global population, yet currently it is Western markets which lead vaccine sales. This hasn't stopped companies from investing in Asian vaccine markets. The graying of the population in Asia and the growth in some regions...Published: April 1, 2011 | Price: $150.00 – $300.00
Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. However, during the past two decades, there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts. In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the...Published: April 1, 2011 | Price: $150.00 – $300.00
Medical device manufacturers are under pressure to reduce costs and improve margins and outsourcing at least some operations is increasingly a tactic for the top original equipment manufacturers (OEMs). There are hundreds of firms who specialize in device making operations and many more companies that do some medical device work. Kalorama's Contract Manufacturing in Medical Devices (Materials, Processing, Electronics, Finished Products) is a complete study of the market and opportunity for outsourcing finished medical devices or a part of a...Published: April 1, 2011 | Price: $150.00 – $300.00
This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients) Parenteral Nutrition For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates,...Published: April 1, 2011 | Price: $150.00 – $300.00
The medical device market is vast -- everything from a large imaging system to a disposable item can be classified as a type of medical device -- but also provides opportunity for new entrants. While in dollar terms the pharmaceutical market is greater, the device market has more participants and is responsible for more orders and transactions. Throughout the past decade, Kalorama Information has covered many device markets in detail. Certain areas such as infusion pumps, patient monitoring and catheters...Published: April 1, 2011 | Price: $150.00 – $300.00
The aging of the population, namely the baby boomer demographic segment, is driving the market for facial rejuvenation products. The size and wealth of this aging segment and its overwhelming desire to retain a youthful appearance are driving growth for aesthetic procedures. Worldwide, billions of dollars are spent annually on facial rejuvenation products and services. This comprehensive report from Kalorama Information, Facial Rejuvenation Markets Worldwide, covers both products and services in this dynamic market. For this report, products pertain to:...Published: May 1, 2011 | Price: $150.00 – $300.00
Kalorama Information's Surgical Procedure Volumes in Europe puts the increasing surgeries worldwide in context with a look at healthcare systems in the top EU countries and statistics on the ten most common procedures. This report provides procedure volumes and forecasts of surgeries in the following countries: United Kingdom France Italy Germany Spain The following surgical procedures are covered in this report: Arthroscopic Joint Replacement Cataract Hips Breast Augmentation Peripheral Vascular Surgery Cesarean Section Spinal Motion Knees Liposuction Blepharoplasty For each...Published: May 1, 2011 | Price: $150.00 – $300.00
Convenience clinics, also known as retail health clinics, are a quickly growing segment of the U.S. health care marketplace, although their expansion has slowed somewhat from the very high rates of their early years. This report looks at retail clinics’ impact and growth over the next five years. Although different operators employ slightly different approaches, the overall business model utilized by convenience clinics is quite consistent. It involves the provision of basic healthcare services at a low cost, in a...Published: May 1, 2011 | Price: $150.00 – $300.00
This report is a complete international focus on the orthopedic biomaterials market. Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials used in orthopedic surgery include autografts, allografts, xenografts, ceramics, polymers, bone growth factors and synovial fluid substitutes. Among the prominent applications for orthopedic biomaterials are surface coatings for hip prostheses, bone cements, bone defect...Published: May 1, 2011 | Price: $150.00 – $300.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead the market now and what can we expect to see in the coming years? Find out in Kalorama Information's report, What's Next in Biologics?, which represents our latest research into the market for non-vaccine biological...Published: June 1, 2011 | Price: $150.00 – $300.00
There is much discussion about emerging markets in in vitro diagnostics, especially the BRIC nations - Brazil, Russia, India and China. Which companies have been successful in these markets and how have they accomplished it? What kind of realistic growth can marketers expect by selling products in these areas? This report is intended to provide an overview of trends and developments in the IVD industry as it applies to emerging markets and the BRIC countries in particular. A Realistic Look...Published: June 1, 2011 | Price: $150.00 – $300.00
This report looks at both the equipment and service aspects of the dialysis industry. The industry enjoys a unique place in the healthcare sector. The industry encompasses two very lucrative segments -- the medical device industry (dialysis products and supplies segment) and the healthcare services industry (dialysis services segment). The dialysis industry remains a robust, multi-billion dollar business that has managed to fuel its growth engine in the past 5 years. What makes this market more interesting and challenging is...Published: June 1, 2011 | Price: $150.00 – $300.00
The wound care industry is a highly diverse and competitive arena - including everything from standard products such as dry bandages to sophisticated hydrogels and alginate dressings, and encompassing artificial skin and anti-infectives used in wound care. The aging population and more prevalent conditions such as diabetes are driving wound care, and these trends are all influenced by future demographic trends, economic uncertainty, the impact of health care reform, increasing numbers of uninsured patients, reimbursement pressures from third party payers,...Published: July 1, 2011 | Price: $150.00 – $225.00
The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Kalorama Information has been closely following vaccine markets and has instituted a yearly market research report schedule since 2003 in order to keep up with fast-moving...Published: July 1, 2011 | Price: $150.00 – $300.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a nosocomial infection (or more generically healthcare-associated infections). The industry has responded with a variety of testing and treatment products. This report, Hospital-Acquired Infections: Diagnostic Markets and Testing Developments,...Published: July 1, 2011 | Price: $150.00 – $300.00
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and more elusive in the near future, as shown in the analysis in this report. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry and the needle-free drug delivery market will continue to grow rapidly. This Kalorama Information report, Needle-Free Drug Delivery: The Market for Alternatives...